Study Whose Purpose is to Find an Optimal Dose for the Treatment With AK 3012 in Patients With Actinic Keratosis
Status:
Completed
Trial end date:
2014-01-01
Target enrollment:
Participant gender:
Summary
In this three-armed dose-finding trial 3 AK 3012 topical formulations shall be investigated
with respect to safety and efficacy in order to identify the optimal concentration in the
topical formulation.
The main objective of the trial is to determine the optimal concentration of the active agent
in the topical formulation as quantified by the change of the number of skin alterations in
pre-defined areas in a time period from inclusion in the trial until the end of treatment (3
months) or prior complete healing.